Brief: Sellas Life Sciences Announces Closing Of $20 Million Registered Direct Offering And Concurrent Private Placement
19/03/2024 22:19
March 19 (Reuters) - Sellas Life Sciences Group Inc
SLS.O :
* SELLAS LIFE SCIENCES GROUP ANNOUNCES CLOSING OF $20
MILLION
REGISTERED DIRECT OFFERING AND CONCURRENT PRIVATE PLACEMENT
PRICED AT-THE-MARKET UNDER NASDAQ RULES
Source text for Eikon: ID:nGNXc4BkqN
Further company coverage: SLS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Sellas Life Sciences
See all newsBrief: Sellas Life Sciences Reaches 80Th Event In Phase 3 Regal Trial Of Galinpepimut-S (Gps) In Acute Myeloid Leukemia
SELLAS Life Sciences Q2 net loss widens on higher expenses
Brief: SELLAS Life Sciences Q2 Net Income USD -9.605 Million
Arbitrator Dismisses Company's Claims In Arbitration Against 3D Medicines On July 24, 2026 - SEC Filing
SELLAS Life Sciences Q1 net loss widens on higher expenses